tiprankstipranks
Piper downgrades Kronos Bio on istisociclib discontinuation
PremiumThe FlyPiper downgrades Kronos Bio on istisociclib discontinuation
1M ago
Kronos Bio downgraded to Hold from Buy at TD Cowen
Premium
The Fly
Kronos Bio downgraded to Hold from Buy at TD Cowen
1M ago
Kronos Bio downgraded to Neutral from Overweight at Piper Sandler
Premium
The Fly
Kronos Bio downgraded to Neutral from Overweight at Piper Sandler
1M ago
Kronos Bio announces preclinical data from p300 KAT inhibitor program
PremiumThe FlyKronos Bio announces preclinical data from p300 KAT inhibitor program
2M ago
Kronos Bio to present data from p300 KAT inhibitor program
Premium
The Fly
Kronos Bio to present data from p300 KAT inhibitor program
2M ago
Kronos Bio nominates development candidate for Sjogren’s Disease
Premium
The Fly
Kronos Bio nominates development candidate for Sjogren’s Disease
3M ago
Kronos Bio appoints Deborah Knobelman as COO, CFO
PremiumThe FlyKronos Bio appoints Deborah Knobelman as COO, CFO
7M ago
Kronos Bio reports Q1 EPS (50c), consensus (42c)
Premium
The Fly
Kronos Bio reports Q1 EPS (50c), consensus (42c)
8M ago
Kronos Bio price target lowered to $2.25 from $2.50 at H.C. Wainwright
Premium
The Fly
Kronos Bio price target lowered to $2.25 from $2.50 at H.C. Wainwright
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100